NDC 81816-001-01 and NDC 81816-001-30), these exact codes are officially indexed in DailyMed under REMY Biosciences, Inc. for the NEOLINN (lidocaine, menthol) patch. belong entirely to Remy Biosciences, Inc. Univec does not hold an independent drug listing or labeler code in these federal registries.
An NDC listing on DailyMed confirms the product is a standard OTC item (like typical pain patches sold in stores). It does not grant prescription ("Rx Only"
They include "Univec eDRLS / NDC" in that diagram for two key reasons: investor perception and distributor ownership. By placing "Univec eDRLS / NDC" in the center of the workflow, the promotional graphics suggest Univec owns a critical, proprietary step in the drug delivery chain. It reassures OTC stock investors that Univec holds valuable FDA-linked infrastructure rather than just outsourcing everything to Remy Biosciences. A brand owner (like Univec) doesn't have to manufacture the drug, but they can apply to become a Private Label Distributor (PLD).
As of now, Univec has not executed its own active NDC listings in the database (relying on Remy's Labeler Code `81816`). Including "Univec eDRLS / NDC" in the process flow signals to investors that Univec intends to obtain its own direct PLD listing eventually, even if it hasn't actually happened yet.
Dalton posted he had applied for the NDC Code close 2 months ago: - Univec's delay in securing its own NDC is due to backend administrative paperwork issues. An NDC listing requires formal confirmation from the contract manufacturing organization (CMO) that the facility is registered and linked to the specific labeler file. Coordinating data entries between Univec and a third-party CDMO creates back-and-forth delays.
Mike Lehr (This is the Gentalman who puts it all together with an outstanding Resume)
Head of Partnerships
Mike supports strategic partnerships and business development, helping expand 11Three’s network of industry, commercialization, and collaborative relationships.
PL